Snapshot
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Antibody
- Hormone
- Growth Factors
- Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
- Asia-Pacific (China, India, Japan, Southeast Asia etc.)
- South America (Brazil, Argentina etc.)
- Middle East & Africa (Saudi Arabia, South Africa etc.)
Global Biologics and Biosimilars Market Analysis 2016-2020 and Forecast 2021-2026
Table of Contents
1 Industry Overview
1.1 Biologics and Biosimilars Industry
Figure Biologics and Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Biologics and Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Biologics and Biosimilars
1.2.2 Downstream
Table Application Segment of Biologics and Biosimilars
Table Global Biologics and Biosimilars Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biologics and Biosimilars Market by Type
3.1 By Type
3.1.1 Antibody
Table Major Company List of Antibody
3.1.2 Hormone
Table Major Company List of Hormone
3.1.3 Growth Factors
Table Major Company List of Growth Factors
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Biologics and Biosimilars Market 2016-2020, by Type, in USD Million
Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in USD Million
Table Global Biologics and Biosimilars Market 2016-2020, by Type, in Volume
Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Roche (Company Profile, Sales Data etc.)
4.1.1 Roche Profile
Table Roche Overview List
4.1.2 Roche Products & Services
4.1.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen (Company Profile, Sales Data etc.)
4.2.1 Amgen Profile
Table Amgen Overview List
4.2.2 Amgen Products & Services
4.2.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 AbbVie (Company Profile, Sales Data etc.)
4.3.1 AbbVie Profile
Table AbbVie Overview List
4.3.2 AbbVie Products & Services
4.3.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
4.4.1 Sanofi-Aventis Profile
Table Sanofi-Aventis Overview List
4.4.2 Sanofi-Aventis Products & Services
4.4.3 Sanofi-Aventis Business Operation Conditions
Table Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
4.5.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.5.2 Johnson & Johnson Products & Services
4.5.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Pfizer (Company Profile, Sales Data etc.)
4.6.1 Pfizer Profile
Table Pfizer Overview List
4.6.2 Pfizer Products & Services
4.6.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Novo Nordisk (Company Profile, Sales Data etc.)
4.7.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
4.7.2 Novo Nordisk Products & Services
4.7.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Eli Lilly (Company Profile, Sales Data etc.)
4.8.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.8.2 Eli Lilly Products & Services
4.8.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Novartis (Company Profile, Sales Data etc.)
4.9.1 Novartis Profile
Table Novartis Overview List
4.9.2 Novartis Products & Services
4.9.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merck (Company Profile, Sales Data etc.)
4.10.1 Merck Profile
Table Merck Overview List
4.10.2 Merck Products & Services
4.10.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 3sbio (Company Profile, Sales Data etc.)
4.11.1 3sbio Profile
Table 3sbio Overview List
4.11.2 3sbio Products & Services
4.11.3 3sbio Business Operation Conditions
Table Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Changchun High Tech (Company Profile, Sales Data etc.)
4.12.1 Changchun High Tech Profile
Table Changchun High Tech Overview List
4.12.2 Changchun High Tech Products & Services
4.12.3 Changchun High Tech Business Operation Conditions
Table Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
4.13 CP Guojian (Company Profile, Sales Data etc.)
4.13.1 CP Guojian Profile
Table CP Guojian Overview List
4.13.2 CP Guojian Products & Services
4.13.3 CP Guojian Business Operation Conditions
Table Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Biotech (Company Profile, Sales Data etc.)
4.14.1 Biotech Profile
Table Biotech Overview List
4.14.2 Biotech Products & Services
4.14.3 Biotech Business Operation Conditions
Table Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
4.15 Gelgen (Company Profile, Sales Data etc.)
4.15.1 Gelgen Profile
Table Gelgen Overview List
4.15.2 Gelgen Products & Services
4.15.3 Gelgen Business Operation Conditions
Table Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
4.16 Innovent (Company Profile, Sales Data etc.)
4.16.1 Innovent Profile
Table Innovent Overview List
4.16.2 Innovent Products & Services
4.16.3 Innovent Business Operation Conditions
Table Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
4.17 Dong Bao (Company Profile, Sales Data etc.)
4.17.1 Dong Bao Profile
Table Dong Bao Overview List
4.17.2 Dong Bao Products & Services
4.17.3 Dong Bao Business Operation Conditions
Table Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
4.18 Ganlee (Company Profile, Sales Data etc.)
4.18.1 Ganlee Profile
Table Ganlee Overview List
4.18.2 Ganlee Products & Services
4.18.3 Ganlee Business Operation Conditions
Table Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
4.19 United Laboratories (Company Profile, Sales Data etc.)
4.19.1 United Laboratories Profile
Table United Laboratories Overview List
4.19.2 United Laboratories Products & Services
4.19.3 United Laboratories Business Operation Conditions
Table Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Biologics and Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Biologics and Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
Table Global Biologics and Biosimilars Sales Volume 2016-2020, by Company, in Volume
Table Global Biologics and Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Biologics and Biosimilars Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Biologics and Biosimilars Market Concentration, in 2020
Figure Europe Biologics and Biosimilars Market Market Concentration, in 2020
Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2020
Figure South America Biologics and Biosimilars Market Concentration, in 2020
Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Tumor
Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in USD Million
Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in Volume
6.1.2 Demand in Diabetes
Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in USD Million
Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in Volume
6.1.3 Demand in Cardiovascular
Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
6.1.4 Demand in Hemophilia
Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in USD Million
Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in Volume
6.1.5 Demand in Others
Figure Biologics and Biosimilars Demand in Others, 2016-2020, in USD Million
Figure Biologics and Biosimilars Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
Figure Biologics and Biosimilars Market Growth 2021-2026, by Application, in USD Million
Figure Biologics and Biosimilars Market Share in 2026, by Application, in USD Million
Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in Volume
Table Biologics and Biosimilars Market Growth 2021-2026, by Application, in Volume
Table Biologics and Biosimilars Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Biologics and Biosimilars Production 2016-2020, by Region, in USD Million
Table Biologics and Biosimilars Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Biologics and Biosimilars Market 2016-2020, by Region, in USD Million
Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in USD Million
Table Global Biologics and Biosimilars Market 2016-2020, by Region, in Volume
Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in USD Million
Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Biologics and Biosimilars
2. Table Application Segment of Biologics and Biosimilars
3. Table Global Biologics and Biosimilars Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Hormone
5. Table Major Company List of Growth Factors
6. Table Major Company List of Others
7. Table Global Biologics and Biosimilars Market 2016-2020, by Type, in USD Million
8. Table Global Biologics and Biosimilars Market 2016-2020, by Type, in Volume
9. Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in USD Million
10. Table Global Biologics and Biosimilars Market Forecast 2021-2026, by Type, in Volume
11. Table Roche Overview List
12. Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Amgen Overview List
14. Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table AbbVie Overview List
16. Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Sanofi-Aventis Overview List
18. Table Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Johnson & Johnson Overview List
20. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Pfizer Overview List
22. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Novo Nordisk Overview List
24. Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Eli Lilly Overview List
26. Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Novartis Overview List
28. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Merck Overview List
30. Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table 3sbio Overview List
32. Table Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Changchun High Tech Overview List
34. Table Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
35. Table CP Guojian Overview List
36. Table Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
37. Table Biotech Overview List
38. Table Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
39. Table Gelgen Overview List
40. Table Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
41. Table Innovent Overview List
42. Table Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
43. Table Dong Bao Overview List
44. Table Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
45. Table Ganlee Overview List
46. Table Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
47. Table United Laboratories Overview List
48. Table Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
49. Table Global Biologics and Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
50. Table Global Biologics and Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
51. Table Global Biologics and Biosimilars Sales Volume 2016-2020, by Company, in Volume
52. Table Global Biologics and Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
53. Table Regional Demand Comparison List
54. Table Major Application in Different Regions
55. Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
56. Table Biologics and Biosimilars Demand Forecast 2021-2026, by Application, in Volume
57. Table Biologics and Biosimilars Market Growth 2021-2026, by Application, in Volume
58. Table Biologics and Biosimilars Market Share in 2026, by Application, in Volume
59. Table Biologics and Biosimilars Production 2016-2020, by Region, in USD Million
60. Table Biologics and Biosimilars Production 2016-2020, by Region, in Volume
61. Table Global Biologics and Biosimilars Market 2016-2020, by Region, in USD Million
62. Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in USD Million
63. Table Global Biologics and Biosimilars Market 2016-2020, by Region, in Volume
64. Table Global Biologics and Biosimilars Market Share 2016-2020, by Region, in Volume
65. Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
66. Table North America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
67. Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
68. Table Europe Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
69. Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
70. Table Asia-Pacific Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
71. Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
72. Table South America Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
73. Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in USD Million
74. Table Middle East & Africa Biologics and Biosimilars Market Size 2016-2020, by Country, in Volume
75. Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in USD Million
76. Table Biologics and Biosimilars Market Forecast 2021-2026, by Region, in Volume
77. Table Price Factors List
List of Figure
1. Figure Biologics and Biosimilars Industry Chain Structure
2. Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Biologics and Biosimilars Market Growth 2016-2020, by Type, in Volume
4. Figure Global Biologics and Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Biologics and Biosimilars Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Biologics and Biosimilars Market Concentration, in 2020
7. Figure Europe Biologics and Biosimilars Market Market Concentration, in 2020
8. Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2020
9. Figure South America Biologics and Biosimilars Market Concentration, in 2020
10. Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2020
11. Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in USD Million
12. Figure Biologics and Biosimilars Demand in Tumor, 2016-2020, in Volume
13. Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in USD Million
14. Figure Biologics and Biosimilars Demand in Diabetes, 2016-2020, in Volume
15. Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
16. Figure Biologics and Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
17. Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in USD Million
18. Figure Biologics and Biosimilars Demand in Hemophilia, 2016-2020, in Volume
19. Figure Biologics and Biosimilars Demand in Others, 2016-2020, in USD Million
20. Figure Biologics and Biosimilars Demand in Others, 2016-2020, in Volume
21. Figure Biologics and Biosimilars Market Growth 2021-2026, by Application, in USD Million
22. Figure Biologics and Biosimilars Market Share in 2026, by Application, in USD Million
23. Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
24. Figure North America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
25. Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
26. Figure Europe Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
27. Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
28. Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
29. Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
30. Figure South America Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
31. Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in USD Million
32. Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2016-2020, in Volume
33. Figure Marketing Channels Overview
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
